One-Dose drug eases breast pain after pregnancy loss
NCT ID NCT06029673
First seen Nov 01, 2025 · Last updated Jun 15, 2026 · Updated 32 times
Summary
This study tested whether a single dose of cabergoline can prevent breast pain, engorgement, and milk leakage in people who had an abortion or pregnancy loss between 16 and 20 weeks. 69 participants took either the drug or a placebo and reported their symptoms. The goal is to reduce physical and emotional distress after an already difficult experience.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LACTATION SUPPRESSED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Planned Parenthood - San Jose Central Health Center
San Jose, California, 95126, United States
-
Stanford University
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.